Abstract
Docking and scoring is currently one of the tools used for hit finding and hit-to-lead optimization when structural information about the target is known. Docking scores have been found useful for optimizing ligand binding to reproduce experimentally observed binding modes. The question is, can docking and scoring be used reliably for hit-to-lead optimization? To illustrate the challenges of scoring for hit-to-lead optimization, the relationship of docking scores with experimentally determined IC50 values measured in-house were tested. The influences of the particular target, crystal structure, and the precision of the scoring function on the ability to differentiate between actives and inactives were analyzed by calculating the area under the curve of receiver operator characteristic curves for docking scores. It was found that for the test sets considered, MW and sometimes ClogP were as useful as GlideScores and no significant difference was observed between SP and XP scores for differentiating between actives and inactives. Interpretation by an expert is still required to successfully utilize docking and scoring in hit-to-lead optimization.





Similar content being viewed by others
References
Gschwend DA, Good AC, Kuntz ID (1996) J Mol Recog 9:175
Perola E, Walters WP, Charifson PS (2004) Proteins 56:235
Muegge I, Rarey M (2001) In: Boyd DB, Lipkowitz KB (eds) Reviews in computational chemistry, vol 17. Wiley-VCH, New York, Ch 1, p 1
Muegge I, Enyedy I (2003) In: Abraham D (ed) Burger’s medicinal chemistry 5th edn. vol 1. Wiley, New York, p 243
Muegge I, Enyedy I (2004) In: Bultinck P, De Winter H, Langenaeker W, Tollenaere J (eds) Computational medicinal chemistry for drug discovery. Marcel Dekker Inc, New York, p 405
Muegge I, Enyedy IJ (2004) Curr Med Chem 11:693
Bissantz C, Folkers G, Rognan D (2000) J Med Chem 43:4759
Kroemer RT (2003) Biochem Soc Trans 31:980
Cotesta S, Giordanetto F, Trosset JY, Crivori P, Kroemer RT, Stouten PFW, Vulpetti A (2005) Proteins 60:629
Stouten PFW, Kroemer RT (2006) Comprehensive Medicinal Chemistry II 4:255
Kroemer RT (2007) Curr Protein Pept Sci 8:312
Wang R, Lu Y, Wang S (2003) J Med Chem 46:2287
Smith R, Hubbard RE, Gschwend DA, Leach AR, Good AC (2003) J Mol Graphics Model 22:41
Ferrara P, Gohlke H, Price DJ, Klebe G, Brooks CL III (2004) J Med Chem 47:3032
Kontoyianni M, McClellan LM, Sokol GS (2004) J Med Chem 47:558
Kontoyianni M, Sokol GS, McClellan LM (2005) J Comput Chem 26:11
Cummings MD, DesJarlais RL, Gibbs AC, Mohan V, Jaeger EP (2005) J Med Chem 48:962
Warren GL, Andrews CW, Capelli AM, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID, Woolven JM, Peishoff CE, Head MS (2006) J Med Chem 49:5912
Zhou Z, Felts AK, Friesner RA, Levy RM (2007) J Chem Inf Model 47:1599
McGaughey GB, Sheridan RP, Bayly CI, Culberson JC, Kreatsoulas C, Lindsley S, Maiorov V, Truchon JF, Cornell WD (2007) J Chem Inf Model 47:1504
Vangrevelinghe E, Zimmermann K, Schoepfer J, Portmann R, Fabbro D, Furet P (2003) J Med Chem 46:2656
Enyedy IJ, Ling Y, Nacro K, Tomita Y, Wu X, Cao Y, Guo R, Li B, Zhu X, Huang Y, Long Y-Q, Roller P, Yang D, Wang S (2001) J Med Chem 44:4313
Enyedy IJ, Lee S-L, Kuo AH, Dickson RB, Lin C-Y, Wang S (2001) J Med Chem 44:1349
Tirado-Rives J, Jorgensen WL (2006) J Med Chem 49:5880
Leach AR, Shoichet BK, Peishoff CE (2006) J Med Chem 49:5851
Bytheway I, Cochran S (2004) J Med Chem 47:1683
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) J Med Chem 49:6177
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindialov IN, Bourne PE (2000) Nucleic Acids Res 28:235
Miyazaki Y, Matsunaga S, Tang J, Maeda Y, Nakano M, Philippe RJ, Shibahara M, Liu W, Sato H, Wang L, Nolte RT (2005) Bioorg Med Chem Lett 15:2203
Hodous BL, Geuns-Meyer SD, Hughes PE, Albrecht BK, Bellon S, Bready J, Caenepeel S, Cee VJ, Chaffee SC, Coxon A, Emery M, Fretland J, Gallant P, Gu Y, Hoffman D, Johnson RE, Kendall R, Kim JL, Long AM, Morrison M, Olivieri PR, Patel VF, Polverino A, Rose P, Tempest P, Wang L, Whittington DA, Zhao H (2007) J Med Chem 50:611
Davies TG, Tunnah P, Meijer L, Marko D, Eisenbrand G, Endicott JA, Noble MEM (2001) Structure 9:389
Brown NR, Noble ME, Endicott JA, Johnson LN (1999) Nat Cell Biol 1:438
Nagar B, Bornmann WG, Pellicena P, Schindler T, Veach DR, Miller WT, Clarkson B, Kuriyan J (2002) Cancer Res 62:4236
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) J Med Chem 47:1739
Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) J Med Chem 47:1750
Maestro, version 8.0.110, (2007) Schrodinger LLC, New York
LigPrep, version 1.2, (2007) Schrodinger LLC, New York
MacroModel, version 9.5.213, (2007) Schrodinger LLC, New York
Still WC, Tempczyk A, Hawley RC, Hendrickson T (1990) J Am Chem Soc 112:6127
Triballeau N, Acher F, Brabet I, Pin JP, Bertrand HO (2005) J Med Chem 48:2534
Kornev AP, Haste NM, Taylor SS, Ten Eyck LF (2006) Proc Natl Acad Sci USA 103:17783
Tirado-Rives J, Jorgensen WL (2006) J Med Chem 49:5880
Pearlman DA, Charifson PS (2001) J Med Chem 44:3417
Triballeau N, Acher F, Brabet I, Pin JP, Bertrand HO (2005) J Med Chem 48:2534
Hanley JA, McNeil BJ (1982) Radiology 143:29
Verma S, Nagarathnam D, Shao J, Zhang L, Zhao J, Wang Y, Li T, Mull E, Enyedy I, Wang C, Zhu Q, Altieri M, Jordan J, Dang TTA, Reddy S (2005) Bioorg Med Chem Lett 15:1973
Page CS, Bates PA (2006) J Comput Chem 27:1990
Coupez B, Lewis RA (2006) Curr Med Chem 13:2995
Sheu SH, Kaya T, Waxman DJ, Vajda S (2005) Biochemistry 44:1193
Prasad JC, Goldstone JV, Camacho CJ, Vajda S, Stegeman JJ (2007) Biochemistry 46:2640
Wang J, Hou T, Xu X (2006) Curr Comput Aided Drug Des 2:287
Xiong Y, Li Y, He H, Zhan CG (2007) Bioorg Med Chem Lett 17:5186
Ferrari AM, Degliesposti G, Sgobba M, Rastelli G (2007) Bioorg Med Chem 15:7865
Zhou Z, Bates M, Madura JD (2006) Proteins 65:580
Lyne PD, Lamb ML, Saeh JC (2006) J Med Chem 49:4805
Acknowledgment
The authors thank Robert Pearlstein, Richard Lewis, and Hanneke Jansen for their reviews of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Enyedy, I.J., Egan, W.J. Can we use docking and scoring for hit-to-lead optimization?. J Comput Aided Mol Des 22, 161–168 (2008). https://doi.org/10.1007/s10822-007-9165-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-007-9165-4